The purpose of this study is to evaluate the Genesis Electrical Impedance Tomography (EIT) imaging system for use in pediatric respiratory disease populations including neuromuscular and bronchopulmonary dysplasia, as well as in age and height matched controls. The EIT does not use radiation, and is read through electrodes.
2 weeks old - 40 years old
Premature infants with current age >2 weeks with a confirmed diagnosis of BPD based on NIH criteria
Or Chronic respiratory disease due to underlying neuromuscular disease
Or confirmed neuromuscular disease with an echo completed within the preceding 12 months of study participation of DMD or other diagnoses associated with mild cardiomyopathy.
<2 weeks of age
Congenital diaphragmatic hernia
Severe congenital heart disease
Significant genetic abnoralities
7
Trial groupsSee each trial group below.